Form 4: OptimizeRx Corp: Executive Sells Shares

OptimizeRx Corp's Chief Commercial Officer, Theresa Greco, reported a disposition of company shares on May 15, 2026, primarily to cover tax obligations upon the vesting of restricted stock units.

Summary

• Theresa Greco, Chief Commercial Officer of OptimizeRx Corp, engaged in a transaction involving company common stock on May 15, 2026.
• A total of 914 shares were disposed of at a price of $5.21 per share.
• This disposition was a result of shares being withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations upon the vesting of restricted stock units.
• Following this transaction, Greco beneficially owns 71,075 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While a disposition of shares by an executive can sometimes raise concerns, the clear explanation of tax withholding upon RSU vesting mitigates significant negative sentiment.

Negatives

• Disposition of shares by a key executive, although explained as a tax withholding event, can sometimes be perceived negatively by the market.

Risks

• The disposition of shares by a Chief Commercial Officer could be interpreted as a lack of confidence in future stock performance, although the filing clarifies it's for tax withholding.
• Potential for negative market perception if the tax withholding explanation is not clearly understood by investors.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it pertains to a change in beneficial ownership.

Management Comments

• The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

Industry Context

StockSavvy.ai notes that insider transactions, particularly Form 4 filings, are routine for executives managing compensation tied to stock. The primary driver here appears to be tax obligations, a common occurrence when restricted stock units vest.

Stakeholder Impact

• Shareholders: The disposition is for tax purposes and does not necessarily indicate a change in the executive's long-term view of the company's prospects. However, any sale of shares by insiders can be scrutinized.
• Employees: This transaction is specific to the executive's compensation and vesting schedule and is unlikely to have a direct impact on other employees.
• Management: The transaction is a standard part of executive compensation and tax management.

Next Steps

• Continued monitoring of insider transactions for any further changes in beneficial ownership.

Key Dates

Keywords

OptimizeRx Corp, OPRX, Form 4, Insider Transaction, Stock Disposition, Theresa Greco, Chief Commercial Officer, Restricted Stock Units, Tax Withholding